A Sleeping Beauty Transposon Screen identified Acvr1b as a gene whose disruption, in combination with oncogenic KRAS, promotes pancreatic adenocarcinoma in vivo24. This evidence concerns the gene ACVR1B and pancreatic adenocarcinoma.